Dr. Manoela Braga

Division of Endocrinology and Metabolism

Manoela Braga


Associate Professor, Division of Endocrinology and Metabolism, Department of Medicine

Active Staff, St. Joseph's Healthcare Hamilton




Education and Professional Standing

Dr. Braga graduated from the Federal University of Minas Gerais, Brazil in 1999 and completed her residency in Internal Medicine and Endocrinology in Brazil followed by a Master’s degree in Health Science.

She then completed a 2 year Research Fellowship with focus on Diabetes and Metabolic Risk at St. Michael’s Hospital- University of Toronto and after that came to McMaster University as a Clinical Fellow in the Division of Endocrinology. She joined the faculty in 2010 as an Assistant Professor in the Department of Medicine, Division of Endocrinology & Metabolism. 

Dr. Braga is a clinician educator involved in both undergraduate and postgraduate teaching. She is also actively involved in the Endocrinology and Metabolism Residency Training Program.  

Dr. Braga’s clinical practice is at St. Joseph’s Hospital and Hamilton Health Science (McMaster site). Clinical interests include management of various endocrine disorders and diabetes. Her research interest is mainly on diabetes with special focus on the application of clinical practice guidelines for the management of diabetes in primary care.  

Selected Publications

  1. Teoh H, Braga MF, Casanova A, Drouin D, Goodman SG, Harris SB, Langer A, Tan MK, Ur E, Yan AT, Zinman B, Leiter LA; on behalf of the T2DM QUERI Investigators. Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI): Patient age, ethnicity, medical history and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets. Diabetes Care. 2010 Dec; 33(12):2558-60.
  2. Braga M, Casanova A, Teoh H, Dawson KC, Gerstein HC, Fitchett DH, Harris SB, Honos G, McFarlane PA, Steele A, Ur E, Yale JF, Langer A, Goodman SG, Leiter LA; Diabetes Registry to Improve Vascular Events (DRIVE) Investigators. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. Can J Cardiol. 2010 Jun; 26(6):297-302.

  3. Gupta M, Szmitko PE, Tsigoulis M, Braga MF, Kajil M, Herjikaka S, Quan A, Teoh H, Verma S. Effects of ezetimibe add-on to statin therapy on adipokine production in patients with metabolic syndrome and stable vascular disease. J Cardiovasc Pharmacol. 2010 Sep;56(3):241-5.

  4. Braga MF, Leiter LA. Role of renin-angiotensin system blockade in patients with diabetes mellitus. Am J Cardiol. 2009 Sep 15;104(6):835-9.

  5. Gupta M, Braga MF, Teoh H, Tsigoulis M, Verma S. Statin effects on LDL and HDL cholesterol in South Asian and white populations. J Clin Pharmacol. 2009 Jul;49(7):831-7.

  6. Braga MF, Langer A, Leiter LA. Recommendations for management of dyslipidemia in high cardiovascular risk patients. Exp Clin Cardiol. 2008 Summer;13(2):71-4.

  7. Braga MF, Grace MG, Lenis J, Kennedy FP, Teplinsky AL, Roederer G, Palumbo PJ, Colin P, Leiter LA. Efficacy and safety of ursodeoxycholic acid in primary, type IIa or IIb hypercholesterolemia: a multicenter, randomized, double-blind clinical trial. Atherosclerosis. 2009 Apr;203(2):479-82.

  8. Gupta M, Braga MF, Verma S. A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol. Can J Cardiol. 2008 Oct;24(10):e65-9.